Tamsulosine des ethoxy Impurity

Tamsulosine des ethoxy Impurity is a structurally modified derivative of tamsulosine, characterized by the absence of an ethoxy substituent at the quinazoline ring's 6-position, replaced by a hydroxyl group. This impurity retains the core tetrahydrofuran and piperazine moieties of the parent drug but exhibits altered polarity due to the hydroxyl functionality. It arises as a synthetic byproduct during ethoxylation steps or via oxidative degradation pathways. This compound serves as a critical HPLC reference standard for quantifying process-related impurities in tamsulosine active pharmaceutical ingredient (API) batches.